Nutritional management of growth faltering in infants aged under six months in Asia and Africa. Study protocol for an individually randomised trial... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/nutritional-management-of-growth-faltering-in-infants-aged-under-six-months-in-asia-and-africa-study-protocol-for-an-individually-randomised-trial-branch
The WHO Department of Maternal, Newborn, Child and Adolescent Health and Ageing (WHO/MCA) will coordinate a multi-country, multi-centre randomised controlled trial to evaluate the effect of approaches
Support for the launch of calls for project proposals against neglected tropical diseases in Benin and Togo (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/support-for-the-launch-of-calls-for-project-proposals-against-neglected-tropical-diseases-in-benin-and-togo
The raison d’être of Anesvad is to improve the health of the most neglected people and communities. A major ongoing quest is the fight against neglected tropical diseases (NTDs) with a focus on skin N
Technical Assistance to Country-Led Evaluations Supported by the Global Financing Facility & Metareview of Evidence (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/technical-assistance-to-country-led-evaluations-supported-by-the-global-financing-facility-metareview-of-evidence
Swiss TPH provides technical assistance to country organisations currently engaged in the implementation of Global Financing Facility (GFF) Investment Case (IC) evaluations, with the aim to strengthen
Literature review on the progress of the 2018 Vaccine Investment Strategy (VIS) (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/literature-review-on-the-progress-of-the-2018-vaccine-investment-strategy-vis
In 2018, the Gavi Board approved the inclusion of Rabies Post-Exposure Prophylaxis (PEP) into the portfolio of vaccines to be funded in the 2021-2025 strategic period. Various challenges were identifi
Clinical Performance Evaluation and Cost-Effectiveness Analysis of miLab platform for Supporting Malaria Control in Target Countries (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/clinical-performance-evaluation-and-cost-effectiveness-analysis-of-milab-platform-for-supporting-malaria-control-in-target-countries
Noul Inc, a South Korean start-up, has developed the miLab(TM) platform, which allows automated sample preparation to imaging and AI analysis of small amounts of blood samples. The platform is of pote
Characterization of field malaria isolates and assessment of the impact of resistance profile on the transmission of resistant strains (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/characterization-of-field-malaria-isolates-and-assessment-of-the-impact-of-resistance-profile-on-the-transmission-of-resistant-strains
This is a joint research project between Swiss Tropical and Public Health Institute (SwissTPH, Switzerland) and Ifakara Health Institute (IHI, Tanzania). Malaria elimination is threatened by resistanc
Lufthygienische Dokumentationsstelle 2018-2021 (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/lufthygienische-dokumentationsstelle-2018-2021
Die vom Bundesamt für Umwelt (BAFU) finanzierte Dokumentationsstelle LUDOK am Schweizerischen Tropen und Public Health Institut (Swiss TPH) liefert seit 30 Jahren evidenzbasierte Informationen zu den
Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre,... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/efficacy-and-safety-of-fexinidazole-in-patients-with-human-african-trypanosomiasis-hat-due-to-trypanosoma-brucei-rhodesiense-a-multicentre-open-label-clinical-trial
A vector-borne parasitic illness, human African trypanosomiasis (HAT), also known as sleeping sickness, is usually fatal without treatment. The less prevalent form, T.b. rhodesiense (r-HAT), is concen
Evolution and Epidemiology of Rifampicin-Resistant Tuberculosis in Khayelitsha, Cape Town: Implications for Biology and Disease Control (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/evolution-and-epidemiology-of-rifampicin-resistant-tuberculosis-in-khayelitsha-cape-town-implications-for-biology-and-disease-control
Background Bacteria resistant to multiple antibiotics are a growing threat for global public health and the economy. Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB
Drug discovery and development for schistosomiasis: From repositioning of antimalarial drug leads and clinical advanced drug candidates to the... (Projects)
https://www.swisstph.ch/fr/projects/project-detail/project/drug-discovery-and-development-for-schistosomiasis-from-repositioning-of-antimalarial-drug-leads-and-clinical-advanced-drug-candidates-to-the-development-of-a-new-paediatric-formulation-of-praziquantel
The aim of my 4-year research project is to identify one or several antischistosomal drug development candidates targeting the haemoglobin degradation pathway and/or other mechanisms with favourable p